What is Phibro Animal Health's SG&A?

Phibro Animal Health (PAHC) reported SG&A of $81.02M in Q1 2026.

How has Phibro Animal Health's SG&A changed year-over-year?

Phibro Animal Health's SG&A increased by 14.0% year-over-year, from $71.05M to $81.02M.

What is the long-term trend for Phibro Animal Health's SG&A?

Over 4 years (2021 to 2025), Phibro Animal Health's SG&A has grown at a 10.2% compound annual growth rate (CAGR), from $196.51M to $289.48M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Phibro Animal Health PAHC SG&A

SG&A at other companies

Merck & Co.MRK

$2.7B+5.8%

ZoetisZTS

$588M+2.4%

Mirum Pharmaceuticals, Inc.MIRM

$96.33M+66.9%

AmgenAMGN

$1.6B-5.0%

Petco Health and Wellness Company, Inc.WOOF

$549.8M-0.7%

Archer Daniels MidlandADM

$961M+3.1%

Segments

By segment

See full

Performance Products$2.24M+5.3%

Mineral Nutrition$1.99M+0.7%

Other financials

Income statement

See full

Revenue$383.5M+10.3%

Gross profit$125.7M+20.2%

Operating income$44.7M+33.2%

Net income$24.0M+15.1%

EPS (diluted)$0.59+15.7%

Balance sheet

See full

Cash & equivalents$54.9M-9.0%

Total debt$32.3M+27.8%

Total equity$361.8M+36.0%

Total assets$1.4B+9.7%

Cash flow

See full

Operating cash flow$16.2M-62.4%

CapEx$15.3M+97.7%

Free cash flow$890.0K-97.5%

Valuation

See full

Market cap$1.27B+31.4%

Enterprise value$1.25B+33.9%

P/E13.4×-17.1×

P/S0.9×0.0×

Profitability

See full

Gross margin32.5%+0.9pp

Operating margin12%+4.0pp

Net margin6.3%+3.7pp

FCF margin0.9%-3.3pp

Returns & leverage

See full

Return on equity30.3%+18.5pp

Debt / equity0.1×0.0×

Current ratio3.2×+0.3×

Where this comes from

Reported directly by Phibro Animal Health in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Phibro Animal Health's SG&A?: Phibro Animal Health (PAHC) reported SG&A of $81.02M in Q1 2026.
How has Phibro Animal Health's SG&A changed year-over-year?: Phibro Animal Health's SG&A increased by 14.0% year-over-year, from $71.05M to $81.02M.
What is the long-term trend for Phibro Animal Health's SG&A?: Over 4 years (2021 to 2025), Phibro Animal Health's SG&A has grown at a 10.2% compound annual growth rate (CAGR), from $196.51M to $289.48M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.